"We appreciate the opportunity to discuss our sub-micron delivery technology and its present and potential applications," says Anna Gluskin, EastGate's CEO. "We look forward to introducing the benefits of such delivery, that is now available through our nutraceutical products currently being sold on the market, to a larger audience,"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.